Summary:
A phase 3b study to evaluate the cardiovascular safety of study drug and allopurinol in subjects with gout and cardiovascular comorbidities.
Qualified Participants Must:
• Be 50 years of age or older
•
Have a history of mi, cardiac or cerebrovascular revascularization procedure, stoke: hospitalized tia, peripheral vascular disease, history of diabetes mellitus with retinopathy, neuropathy, nephropathy, small vessel vascualar disease
•
Have a uric acid level of >6.0%
Qualified Participants May Receive:
Compensation for time and travel, all study related physical exams, lab work, study medication, and rescue medication.